{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:13:59Z","timestamp":1781151239118,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40261-023-01288-1","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:02:19Z","timestamp":1689685339000},"page":"565-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients"],"prefix":"10.1007","volume":"43","author":[{"given":"Shubhadeep D.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avula","family":"Rajamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Reddy","family":"Bandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasa Chary","family":"Sriramadasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvash","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Kothiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saswati","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"Sankerneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidhar","family":"Panapakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Narayana Reddy","family":"Vemireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Vattipalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3458-7287","authenticated-orcid":false,"given":"Srinivas Reddy","family":"Devireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"issue":"5","key":"1288_CR1","first-page":"298","volume":"98","author":"BA Becker","year":"2018","unstructured":"Becker BA, Childress MA. Common foot problems: over-the-counter treatments and home care. Am Fam Physician. 2018;98(5):298\u2013303.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1288_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.pop.2018.05.004","volume":"45","author":"KT Clebak","year":"2018","unstructured":"Clebak KT, Malone MA. Skin infections. Prim Care. 2018;45(3):433\u201354.","journal-title":"Prim Care"},{"issue":"1","key":"1288_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12895-018-0073-1","volume":"18","author":"M Rajagopalan","year":"2018","unstructured":"Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, Godse K, Patel K, Rengasamy M, Rudramurthy S, Dogra S. Expert consensus on the management of dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018;18(1):6.","journal-title":"BMC Dermatol"},{"issue":"3","key":"1288_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3109\/1040841X.2013.856853","volume":"41","author":"M Ilkit","year":"2015","unstructured":"Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015;41(3):374\u201388.","journal-title":"Crit Rev Microbiol"},{"key":"1288_CR5","unstructured":"Nigam PK, Saleh D. Tinea Pedis. In: StatPearls. Treasure Island: StatPearls Publishing Copyright \u00a9 2021, StatPearls Publishing LLC. 2021."},{"issue":"4","key":"1288_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pop.2015.08.004","volume":"42","author":"N Kaushik","year":"2015","unstructured":"Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections. Prim Care. 2015;42(4):501\u201316.","journal-title":"Prim Care"},{"issue":"Suppl 4","key":"1288_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","volume":"51","author":"B Havlickova","year":"2008","unstructured":"Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2.","journal-title":"Mycoses"},{"key":"1288_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11046-008-9100-9","volume":"166","author":"C Seebacher","year":"2008","unstructured":"Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166:335.","journal-title":"Mycopathologia"},{"key":"1288_CR9","doi-asserted-by":"crossref","unstructured":"Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol 2010; 28:197.","DOI":"10.1016\/j.clindermatol.2009.12.005"},{"issue":"1","key":"1288_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ijd.13402","volume":"56","author":"Y Oz","year":"2017","unstructured":"Oz Y, Qoraan I, Oz A, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56(1):68\u201374.","journal-title":"Int J Dermatol"},{"key":"1288_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1128\/AAC.19.3.386","volume":"19","author":"A Georgopoulos","year":"1981","unstructured":"Georgopoulos A, Petranyi G, Mieth H, et al. In vitro activity of naftifine, a new antifungal agent. Antimicrob Agents Chemother. 1981;19:386\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1288_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/0190-9622(90)70288-S","volume":"23","author":"E Jay","year":"1990","unstructured":"Jay E. Birnbaum, Pharmacology of the allylamines. J Am Acad Dermatol. 1990;23(4):782\u20135 (2).","journal-title":"J Am Acad Dermatol"},{"key":"1288_CR13","unstructured":"NAFTIN\u00ae-naftifine hydrochloride gel. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/019356s008,019599s014,204286s003lbl.pdf. Accessed 24 Nov 2022"},{"key":"1288_CR14","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.4103\/CDR.CDR_34_17","volume":"1","author":"SA Poojary","year":"2017","unstructured":"Poojary SA. Topical antifungals: A review and their role in current management of dermatophytoses. Clin Dermatol Rev. 2017;1:S24\u20139.","journal-title":"Clin Dermatol Rev"},{"key":"1288_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1067\/mdm.2001.108128","volume":"13","author":"AK Gupta","year":"2001","unstructured":"Gupta AK, Albreski D, Del Rosso JQ, Konnikov N. The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole to treat onychomycosis and other dermatomycoses. Curr Problems Dermatol. 2001;13:220\u201346.","journal-title":"Curr Problems Dermatol."},{"key":"1288_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2230.1992.tb00246.x","volume":"17","author":"P Suchil","year":"1992","unstructured":"Suchil P, Gei FM, Robles M, et al. Once- weekly oral dose of fluconazole 150 mg in the treatment of tineacorporis\/cruris and cutaneous candidiasis. Clin Exp Dermatol. 1992;17:397\u2013401.","journal-title":"Clin Exp Dermatol"},{"key":"1288_CR17","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1039\/C6MD00222F","volume":"7","author":"HX Ngo","year":"2016","unstructured":"Ngo HX, Garneau-Tsodikova S, Green KD. A complex game of hide and seek: the search for new antifungals. Medchemcomm. 2016;7:1285\u2013306.","journal-title":"Medchemcomm"},{"issue":"5","key":"1288_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-4362.1989.tb01362.x","volume":"28","author":"MA El Darouti","year":"1989","unstructured":"El Darouti MA, Raubaie SAL, Shandrashekhar CR, Sawaf MHAL, Movahadi GA. Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis. Intl J Dermatol. 1989;28(5):345\u20136.","journal-title":"Intl J Dermatol"},{"key":"1288_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1365-4362.1994.tb02899.x","volume":"33","author":"M Nada","year":"1994","unstructured":"Nada M, Hanafi S, Al-Omari H, et al. Naftifine versus miconazole\/hydrocortisone in inflammatory dermatophyte infections. Int J Dermatol. 1994;33:570\u20132.","journal-title":"Int J Dermatol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-023-01288-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01288-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:05:25Z","timestamp":1719317125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-023-01288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s40261-023-01288-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"28 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary material is missing and it has been included","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding for this study was provided by Hetero Labs Limited, Hyderabad, India.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Shubhadeep D. Sinha, Mohan Reddy Bandi, Sreenivasa Chary Sriramadasu, Abhilash Sankerneni, Muralidher Panapakam, Venkata Narayana Reddy Vemireddy and Srinivas Reddy Devireddy are the employees of Hetero Labs Limited. Ramya Vattipalli is a former employee of Hetero Labs Limited. All other authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The data supporting the results reported in the article, which are not available in the article, are available on request if appropriate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was conducted after approval by the institutional review board\/ethics committee at each participating site (Supplementary Material) and in accordance with good clinical practice (GCP) guidelines issued by the Central Drugs Standard Control Organization (CDSCO), New Drugs and Clinical Trials Rules (2019), Indian Council of Medical Research (ICMR) and ethical guidelines for biomedical research on human patients. This trial was performed with the ethical principles that have their origin in the Declaration of Helsinki (2013), that are consistent with GCP in accordance with International Conference on Harmonization guidelines (ICH-GCP E6), the applicable regulatory requirements, and applicable standard operating procedures (SOPs).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients signed written informed consent prior to the initiation of study-related procedures for screening.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not Applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualisation: SDS and SCS; Methodology: SCS and AS; Formal analysis and investigation: AR, RKK, S.S, SH, MP, VNRV and MRB; Writing\u2014original draft preparation: SRD; Writing\u2014review and editing: SCS, SRD, SDS; Supervision: SDS, SCS, and MRB.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}